摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2--oestron-3-methylether | 21003-04-3

中文名称
——
中文别名
——
英文名称
2--oestron-3-methylether
英文别名
(8R,9S,13S,14S)-7,8,9,11,12,13,15,16-octahydro-2-adamantyl-3-methoxy-13-methyl-6H-cyclopenta[a]phenanthrene-17(14H)-one;2-(Adamantyl-(1))-oestron-3-methylether
2-<Adamantyl-(1)>-oestron-3-methylether化学式
CAS
21003-04-3
化学式
C29H38O2
mdl
——
分子量
418.62
InChiKey
QGTVEUIHCNUHKL-DGGJTPRQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.59
  • 重原子数:
    31.0
  • 可旋转键数:
    2.0
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    26.3
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2--oestron-3-methylether甲醇 、 sodium tetrahydroborate 、 sodium hydride 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 3.0h, 生成 (8R,9S,13S,14S)-methyl 7,8,9,11,12,13,14,15,16,17-decahydro-17-hydroxy-2-adamantyl-3-methoxy-13-methyl-6H-cyclopenta[a]phenanthrene-16-carboxylate
    参考文献:
    名称:
    Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders
    摘要:
    Designing novel inverse agonists of NR ROR gamma t still represents a challenge for the pharmaceutical community to develop therapeutics for treating immune diseases. By exploring the structure of NRs natural ligands, the representative arotenoid ligands and RORs specific ligands share some chemical homologies which can be exploited to design a novel molecular structure characterized by a polycyclic core bearing a polar head and a hydrophobic tail. Compound MG 2778 (8), a cyclopenta[a]phenantrene derivative, was identified as lead compound which was chemically modified at position 2 in order to obtain a small library for preliminary SARs. Cell viability and estrogenic activity of compounds 7, 8, 19a, 30, 31 and 32 were evaluated to attest selectivity. The selected 7, 8, 19a and 31 compounds were assayed in a Gal4 UAS-Luc co-transfection system in order to determine their ability to modulate ROR gamma t activity in a cellular environment. They were evaluated as inverse agonists taken ursolic acid as reference compound. The potency of compounds was lower than that of ursolic acid, but their efficacy was similar. Compound 19a was the most active, significantly reducing ROR gamma t activity at low micromolar concentrations. (c) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2018.02.018
  • 作为产物:
    描述:
    雌酚酮三氟化硼乙醚四丁基碘化铵 、 sodium hydroxide 作用下, 以 正己烷二氯甲烷 为溶剂, 反应 7.0h, 生成 2--oestron-3-methylether
    参考文献:
    名称:
    Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders
    摘要:
    Designing novel inverse agonists of NR ROR gamma t still represents a challenge for the pharmaceutical community to develop therapeutics for treating immune diseases. By exploring the structure of NRs natural ligands, the representative arotenoid ligands and RORs specific ligands share some chemical homologies which can be exploited to design a novel molecular structure characterized by a polycyclic core bearing a polar head and a hydrophobic tail. Compound MG 2778 (8), a cyclopenta[a]phenantrene derivative, was identified as lead compound which was chemically modified at position 2 in order to obtain a small library for preliminary SARs. Cell viability and estrogenic activity of compounds 7, 8, 19a, 30, 31 and 32 were evaluated to attest selectivity. The selected 7, 8, 19a and 31 compounds were assayed in a Gal4 UAS-Luc co-transfection system in order to determine their ability to modulate ROR gamma t activity in a cellular environment. They were evaluated as inverse agonists taken ursolic acid as reference compound. The potency of compounds was lower than that of ursolic acid, but their efficacy was similar. Compound 19a was the most active, significantly reducing ROR gamma t activity at low micromolar concentrations. (c) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2018.02.018
点击查看最新优质反应信息

文献信息

  • The adamantyl carbonium ion as a dehydrogenating agent, its reactions with estrone
    作者:W.H.W. Lunn、E. Farkas
    DOI:10.1016/s0040-4020(01)96851-6
    日期:1968.1
    An unusual and useful dehydrogenation of estrone of Δ9(11)-estrone has been observed on its reaction with the adamantyl carbonium ion. With modified conditions both t-butyl and adamantyl carbonium ion sources gave 2-substituted estrone derivatives in this reaction.
    在与金刚烷碳酸根离子反应时,已观察到Δ9 (11) -雌酮雌酮异常且有用的。在改变的条件下,叔丁基和金刚烷离子源均在该反应中得到2-取代的雌酮生物
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B